XML 15 R5.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Statements of Stockholders’ Equity - USD ($)
$ in Thousands
Total
Previously Reported
Revision of Prior Period, Adjustment
Common Stock
Common Stock
Previously Reported
Common Stock
Revision of Prior Period, Adjustment
Treasury Stock
Treasury Stock
Previously Reported
Treasury Stock
Revision of Prior Period, Adjustment
Additional Paid-In Capital
Additional Paid-In Capital
Previously Reported
Additional Paid-In Capital
Revision of Prior Period, Adjustment
Accumulated Other Comprehensive Income (Loss)
Accumulated Other Comprehensive Income (Loss)
Previously Reported
Accumulated Deficit
Accumulated Deficit
Previously Reported
Beginning balance (in shares) at Dec. 31, 2020       114,266,515 73,481,228 40,785,287 0 113,220 (113,220)              
Beginning balance at Dec. 31, 2020 $ 185,917 $ (16,199) $ 202,116 $ 11 $ 735 $ (724) $ 0 $ (352) $ 352 $ 597,274 $ 394,786 $ 202,488 $ (2) $ (2) $ (411,366) $ (411,366)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Issuance of Common Stock upon exercise of options (in shares)       411,789                        
Issuance of Common Stock upon exercise of options 877                 877            
Issuance of Common Stock for services (in shares)       162,737                        
Issuance of Common Stock for services 114                 114            
Stock-based compensation 3,140                 3,140            
Surrender of shares in cashless exercise (in shares)       (15,189)                        
Surrender of shares in cashless exercise (56)                 (56)            
Net unrealized loss on available-for-sale securities (6)                       (6)      
Foreign currency translation gain (loss) 1                       1      
Net loss (9,484)                           (9,484)  
Ending balance (in shares) at Mar. 31, 2021       114,825,852     0                  
Ending balance at Mar. 31, 2021 180,503     $ 11     $ 0     601,349     (7)   (420,850)  
Beginning balance (in shares) at Dec. 31, 2021       181,552,241     0                  
Beginning balance at Dec. 31, 2021 $ 612,024     $ 18     $ 0     1,110,991     (72)   (498,913)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Issuance of Common Stock upon exercise of options (in shares) 624,685     624,685                        
Issuance of Common Stock upon exercise of options $ 1,242                 1,242            
Issuance of Common Stock for services 50                 50            
Stock-based compensation 8,627                 8,627            
Net unrealized loss on available-for-sale securities (652)                       (652)      
Foreign currency translation gain (loss) (3)                       (3)      
Net loss (3,979)                           (3,979)  
Ending balance (in shares) at Mar. 31, 2022       182,176,926     0                  
Ending balance at Mar. 31, 2022 $ 617,309     $ 18     $ 0     $ 1,120,910     $ (727)   $ (502,892)